Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (5)

Search Criteria

  1. DPOH name: KEENE, DANIEL
Share this search Create an alert
Start over
Modify criteria

Refine registrations results by

Refine monthly communication reports results by

Type Subject matter of the communication
Government institution of the DPOH

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Monthly communication reports (5)
Results: 1-5 | Export
  1. Psychedelics Canada—The Canada Psychedelic Businesses Association
    Type: In-house Organization
    Occurred: 2023-06-13
    Posted: 2023-07-27
    Designated public office holders:
    • Carol Anne Chénard, Director, Office of Controlled Substances | Health Canada (HC)
    • Jennifer Pelley, Director, Office of Legislative and Regulatory Affairs | Health Canada (HC)
    • Daniel Keene, Associate Director, Office of Clinical Trials | Health Canada (HC)
    • Kathy Soltys, Director, Office of Clinical Trials | Health Canada (HC)
    Subject matters:
    • Health
    • Science and Technology
    • Justice and Law Enforcement
      •
  2. Psychedelics Canada—The Canada Psychedelic Businesses Association
    Type: In-house Organization
    Occurred: 2022-10-04
    Posted: 2022-11-15
    Designated public office holders:
    • Cesare Spadaccini, Manager, Office of Controlled Substances | Health Canada (HC)
    • Marc-André Roy, Associate Director, Office of Controlled Substances | Health Canada (HC)
    • Jenny-Lee Choon, Acting Manager, Office of Controlled Substances | Health Canada (HC)
    • Jennifer Pelley, Director, Office of Legislative and Regulatory Affairs | Health Canada (HC)
    • Daniel Keene, Associate Director, Office of Clinical Trials | Health Canada (HC)
    • Kristen Beausoleil, Manager, Office of Legislative and Regulatory Affairs | Health Canada (HC)
    • Kathy Soltys, Director, Office of Clinical Trials | Health Canada (HC)
    • Jennifer Saxe, Director General, Controlled Substances Directorate, Controlled Substances and Cannabis Branch | Health Canada (HC)
    • Jaigi Mathai, Senior Evaluator, Office of Clinical Trials | Health Canada (HC)
    • Sarah Schlegelmilch, Senior Policy Analyst, Office of Legislative and Regulatory Affairs | Health Canada (HC)
    • Graeme Simpson, Senior Policy Analyst, Office of Controlled Substances | Health Canada (HC)
    Subject matters:
    • Health
    • Science and Technology
    • Justice and Law Enforcement
      •
  3. Optimind Pharma
    Type: Consultant
    Lobbyist: Summer Senter, Wellington-Dupont Public Affairs
    Occurred: 2022-04-19
    Posted: 2022-05-02
    Designated public office holders:
    • Carole Légaré, Director, Office of Clinical Trials | Health Canada (HC)
    • Jennifer Pelley, Director, Office of Legislative and Regulatory Affairs | Health Canada (HC)
    • Carol Anne Chénard, Director, Office of Controlled Substances | Health Canada (HC)
    • Aqsa Malik, Senior Policy Analyst, Office of Legislative and Regulatory Affairs | Health Canada (HC)
    • Paul Smeaton, Manager of the Quality Division, Office of Clinical Trials | Health Canada (HC)
    • Larissa Lefebvre, Manager, Submissions Management Division, Office of Clinical Trials | Health Canada (HC)
    • Daniel Keene, Associate Director, Office of Clinical Trials | Health Canada (HC)
    Subject matters:
    • Health
      •
  4. Cystic Fibrosis Canada / Fibrose kystique Canada
    Type: In-house Organization
    Occurred: 2021-05-27
    Posted: 2021-06-15
    Designated public office holders:
    • Daniel Keene, Associated Director, Office of Clinical Trials TPD | Health Canada (HC)
    Subject matters:
    • Health
      •
  5. The Hospital for Sick Children (SickKids)
    Type: In-house Organization
    Occurred: 2017-11-24
    Posted: 2017-12-15
    Designated public office holders:
    • Daniel Keene, A/Chief, Clinical Trials Division & Head Drug Safety Unit, Health Products and Food Branch | Health Canada (HC)
    • Chad Sheehy, Manager, Clinical Trial and Biological Product Compliance, Regulatory Operations and Regions Branch | Health Canada (HC)
    • Christopher Antonio, Regulatory Affairs Supervisor, Health Products and Food Branch | Health Canada (HC)
    • Vincent Panetta, Regulatory Affairs Supervisor, Health Products and Food Branch | Health Canada (HC)
    • Emily Griffiths, Policy Analyst, Health Products and Food Branch | Health Canada (HC)
    • Carole Legare, Director, Office of Clinical Trials, Health Products and Food Branch | Health Canada (HC)
    • Agnes Klein, Senior Medical Advisor, DGO, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Health
      •
Date Modified: